ReviewDiscover oncology2026

An evidence informed framework for artificial intelligence in rare breast cancers using small cohort validation synthetic data practices and clinical governance.

Bandar Saad AlshreefPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.